Skip to main content

Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • The U.S. Food and Drug Administration approved the Gastric Emptying Breath Test (GEBT), a new non-invasive test for the treatment of delayed gastric emptying, known as gastroparesis. Gastroparesis is a condition in which your stomach cannot empty itself of food in a normal fashion. It is caused by damage to the vagus nerve, which regulates the digestive system. A damaged vagus nerve prevents the muscles in the stomach and intestine from functioning, preventing food from moving through the digestive system properly. If this left untreated, gastroparesis can lead to problems such as severe dehydration due to persistent vomiting, difficulty managing blood sugar levels in people with diabetes, and malnutrition due to poor absorption of nutrients or a low caloric intake.

  • The cumbersome days of stressful, manual, wired monitoring of the unborn child in pregnant mothers will soon end - thanks to a new system unveiled at a hospital here. The Lokmanya Tilak Municipal General Hospital, known as the Sion Hospital, has introduced system in order to monitor the fetal heart rate and condition of the baby in the uterus of a pregnant lady for the first time in India.

  • Results from the phase 1 clinical trial of an Ebola vaccine based on the current strain of the virus suggests it is safe to use and provokes an immune response in recipients, Chinese scientists say. Until now, all tested Ebola virus vaccines have been based on the virus strain from the Zaire outbreak in 1976.

  • In a world first, researchers have found that a naturally occurring chemical attracts pregnant malaria transmitting mosquitoes - a discovery which could boost malaria control efforts. The chemical, cedrol, found in mosquito breeding sites near Africa's Lake Victoria, could be used in traps that would 'attract and kill' the female mosquito, preventing reproduction before she lays hundreds of eggs.

  • Vitamin D may Help Treat Age related Diseases

    Vitamin D may play a vital role in the prevention and treatment of chronic diseases associated with ageing such as diabetes and cancer, according to new research. Researchers reviewed evidence that suggests an association between vitamin D deficiency and chronic diseases associated with ageing such as cognitive decline, depression, osteoporosis, cardiovascular disease, high blood pressure, Type 2 diabetes and cancer.

  • The US Food and Drug Administration (FDA) has approved the VenaSeal closure system, first device to permanently treat varicose veins of leg by sealing them with an adhesive agent. The VenaSeal Closure system is manufactured by Covidien LLC, based in Morrisville, North Carolina.

  • According to business intelligence provider GBI (GlobalBusinessIntelligence) Research In 2013,  The US treatment market for rheumatoid arthritis (RA) was $6.4 billion and which get rising to $9.3 billion by 2020, representing a Compound Annual Growth Rate (CAGR) of 5.5%. Resaon behind this sudden growth  is US’ increasing prevalent population, which is reported  to hit 1.68 million by 2020. Consequently, marketcurrently makes up the  largest treatmentarea of the eight major pharmaceutical markets (the US, UK, Canada, France, Germany, Spain, Italy and Japan).

    [adsense:336x280:8701650588]

  • Australian researchers have developed a new genome editing technology that can target and kill blood cancer cells with high accuracy. Using the technology, researchers from the Walter and Eliza Hall Institute were able to kill human lymphoma cells by locating and deleting an essential gene for cancer cell survival.

Subscribe to Pharma News